Glucose Monitoring
The research report includes specific segments by region (country), by company, by Type and by Ap ... Read More
Global Gaucher Disease Market Outlook 2023
1 Gaucher Disease Market Overview
1.1 Product Overview and Scope of Gaucher Disease
1.2 Gaucher Disease Segment by Type
1.2.1 Global Gaucher Disease Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Enzyme Replacement Therapy
1.2.3 Substrate Reduction Therapy
1.3 Gaucher Disease Segment by Application
1.3.1 Global Gaucher Disease Sales Comparison by Application: (2021-2027)
1.3.2 Non-neuronopathic Gaucher Disease
1.3.3 Neuronopathic Gaucher Disease
1.4 Global Gaucher Disease Market Size Estimates and Forecasts
1.4.1 Global Gaucher Disease Revenue 2016-2027
1.4.2 Global Gaucher Disease Sales 2016-2027
1.4.3 Gaucher Disease Market Size by Region: 2016 Versus 2021 Versus 2027
2 Gaucher Disease Market Competition by Manufacturers
2.1 Global Gaucher Disease Sales Market Share by Manufacturers (2016-2021)
2.2 Global Gaucher Disease Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Gaucher Disease Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Gaucher Disease Manufacturing Sites, Area Served, Product Type
2.5 Gaucher Disease Market Competitive Situation and Trends
2.5.1 Gaucher Disease Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Gaucher Disease Players Market Share by Revenue
2.5.3 Global Gaucher Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gaucher Disease Retrospective Market Scenario by Region
3.1 Global Gaucher Disease Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Gaucher Disease Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Gaucher Disease Market Facts & Figures by Country
3.3.1 North America Gaucher Disease Sales by Country
3.3.2 North America Gaucher Disease Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Gaucher Disease Market Facts & Figures by Country
3.4.1 Europe Gaucher Disease Sales by Country
3.4.2 Europe Gaucher Disease Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Gaucher Disease Market Facts & Figures by Region
3.5.1 Asia Pacific Gaucher Disease Sales by Region
3.5.2 Asia Pacific Gaucher Disease Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Gaucher Disease Market Facts & Figures by Country
3.6.1 Latin America Gaucher Disease Sales by Country
3.6.2 Latin America Gaucher Disease Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Gaucher Disease Market Facts & Figures by Country
3.7.1 Middle East and Africa Gaucher Disease Sales by Country
3.7.2 Middle East and Africa Gaucher Disease Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Gaucher Disease Historic Market Analysis by Type
4.1 Global Gaucher Disease Sales Market Share by Type (2016-2021)
4.2 Global Gaucher Disease Revenue Market Share by Type (2016-2021)
4.3 Global Gaucher Disease Price by Type (2016-2021)
5 Global Gaucher Disease Historic Market Analysis by Application
5.1 Global Gaucher Disease Sales Market Share by Application (2016-2021)
5.2 Global Gaucher Disease Revenue Market Share by Application (2016-2021)
5.3 Global Gaucher Disease Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Gaucher Disease Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi Gaucher Disease Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Takeda
6.2.1 Takeda Corporation Information
6.2.2 Takeda Description and Business Overview
6.2.3 Takeda Gaucher Disease Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Takeda Gaucher Disease Product Portfolio
6.2.5 Takeda Recent Developments/Updates
6.3 Actelion Pharma
6.3.1 Actelion Pharma Corporation Information
6.3.2 Actelion Pharma Description and Business Overview
6.3.3 Actelion Pharma Gaucher Disease Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Actelion Pharma Gaucher Disease Product Portfolio
6.3.5 Actelion Pharma Recent Developments/Updates
6.4 Pfizer (Protalix)
6.4.1 Pfizer (Protalix) Corporation Information
6.4.2 Pfizer (Protalix) Description and Business Overview
6.4.3 Pfizer (Protalix) Gaucher Disease Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer (Protalix) Gaucher Disease Product Portfolio
6.4.5 Pfizer (Protalix) Recent Developments/Updates
6.5 ISU ABXIS
6.5.1 ISU ABXIS Corporation Information
6.5.2 ISU ABXIS Description and Business Overview
6.5.3 ISU ABXIS Gaucher Disease Sales, Revenue and Gross Margin (2016-2021)
6.5.4 ISU ABXIS Gaucher Disease Product Portfolio
6.5.5 ISU ABXIS Recent Developments/Updates
7 Gaucher Disease Manufacturing Cost Analysis
7.1 Gaucher Disease Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Gaucher Disease
7.4 Gaucher Disease Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Gaucher Disease Distributors List
8.3 Gaucher Disease Customers
9 Gaucher Disease Market Dynamics
9.1 Gaucher Disease Industry Trends
9.2 Gaucher Disease Growth Drivers
9.3 Gaucher Disease Market Challenges
9.4 Gaucher Disease Market Restraints
10 Global Market Forecast
10.1 Gaucher Disease Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Gaucher Disease by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Gaucher Disease by Type (2022-2027)
10.2 Gaucher Disease Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Gaucher Disease by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Gaucher Disease by Application (2022-2027)
10.3 Gaucher Disease Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Gaucher Disease by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Gaucher Disease by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Gaucher Disease Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Gaucher Disease Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Gaucher Disease Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Gaucher Disease Covered in This Study
Table 5. Global Gaucher Disease Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Gaucher Disease Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Gaucher Disease Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Gaucher Disease Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Gaucher Disease Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Gaucher Disease Manufacturing Sites and Area Served
Table 11. Manufacturers Gaucher Disease Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Gaucher Disease by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Gaucher Disease as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Gaucher Disease Sales by Region (2016-2021) & (K Units)
Table 16. Global Gaucher Disease Sales Market Share by Region (2016-2021)
Table 17. Global Gaucher Disease Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Gaucher Disease Sales by Country (2016-2021) & (K Units)
Table 19. North America Gaucher Disease Sales Market Share by Country (2016-2021)
Table 20. North America Gaucher Disease Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Gaucher Disease Revenue Market Share by Country (2016-2021)
Table 22. Europe Gaucher Disease Sales by Country (2016-2021) & (K Units)
Table 23. Europe Gaucher Disease Sales Market Share by Country (2016-2021)
Table 24. Europe Gaucher Disease Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Gaucher Disease Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Gaucher Disease Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Gaucher Disease Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Gaucher Disease Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Gaucher Disease Revenue Market Share by Region (2016-2021)
Table 30. Latin America Gaucher Disease Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Gaucher Disease Sales Market Share by Country (2016-2021)
Table 32. Latin America Gaucher Disease Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Gaucher Disease Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Gaucher Disease Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Gaucher Disease Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Gaucher Disease Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Gaucher Disease Revenue Market Share by Country (2016-2021)
Table 38. Global Gaucher Disease Sales (K Units) by Type (2016-2021)
Table 39. Global Gaucher Disease Sales Market Share by Type (2016-2021)
Table 40. Global Gaucher Disease Revenue (Million US$) by Type (2016-2021)
Table 41. Global Gaucher Disease Revenue Share by Type (2016-2021)
Table 42. Global Gaucher Disease Price (USD/Unit) by Type (2016-2021)
Table 43. Global Gaucher Disease Sales (K Units) by Application (2016-2021)
Table 44. Global Gaucher Disease Sales Market Share by Application (2016-2021)
Table 45. Global Gaucher Disease Revenue (Million US$) by Application (2016-2021)
Table 46. Global Gaucher Disease Revenue Share by Application (2016-2021)
Table 47. Global Gaucher Disease Price (USD/Unit) by Application (2016-2021)
Table 48. Sanofi Corporation Information
Table 49. Sanofi Description and Business Overview
Table 50. Sanofi Gaucher Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Sanofi Gaucher Disease Product
Table 52. Sanofi Recent Developments/Updates
Table 53. Takeda Corporation Information
Table 54. Takeda Description and Business Overview
Table 55. Takeda Gaucher Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Takeda Gaucher Disease Product
Table 57. Takeda Recent Developments/Updates
Table 58. Actelion Pharma Corporation Information
Table 59. Actelion Pharma Description and Business Overview
Table 60. Actelion Pharma Gaucher Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Actelion Pharma Gaucher Disease Product
Table 62. Actelion Pharma Recent Developments/Updates
Table 63. Pfizer (Protalix) Corporation Information
Table 64. Pfizer (Protalix) Description and Business Overview
Table 65. Pfizer (Protalix) Gaucher Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Pfizer (Protalix) Gaucher Disease Product
Table 67. Pfizer (Protalix) Recent Developments/Updates
Table 68. ISU ABXIS Corporation Information
Table 69. ISU ABXIS Description and Business Overview
Table 70. ISU ABXIS Gaucher Disease Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. ISU ABXIS Gaucher Disease Product
Table 72. ISU ABXIS Recent Developments/Updates
Table 73. Production Base and Market Concentration Rate of Raw Material
Table 74. Key Suppliers of Raw Materials
Table 75. Gaucher Disease Distributors List
Table 76. Gaucher Disease Customers List
Table 77. Gaucher Disease Market Trends
Table 78. Gaucher Disease Growth Drivers
Table 79. Gaucher Disease Market Challenges
Table 80. Gaucher Disease Market Restraints
Table 81. Global Gaucher Disease Sales Forecast by Type (2022-2027) & (K Units)
Table 82. Global Gaucher Disease Sales Market Share Forecast by Type (2022-2027)
Table 83. Global Gaucher Disease Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 84. Global Gaucher Disease Revenue Market Share Forecast by Type (2022-2027)
Table 85. Global Gaucher Disease Sales Forecast by Application (2022-2027) & (K Units)
Table 86. Global Gaucher Disease Sales Market Share Forecast by Application (2022-2027)
Table 87. Global Gaucher Disease Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 88. Global Gaucher Disease Revenue Market Share Forecast by Application (2022-2027)
Table 89. Global Gaucher Disease Sales Forecast by Region (2022-2027) & (K Units)
Table 90. Global Gaucher Disease Sales Market Share Forecast by Region (2022-2027)
Table 91. Global Gaucher Disease Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 92. Global Gaucher Disease Revenue Market Share Forecast by Region (2022-2027)
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Gaucher Disease
Figure 2. Global Gaucher Disease Market Share by Type in 2020 & 2027
Figure 3. Enzyme Replacement Therapy Product Picture
Figure 4. Substrate Reduction Therapy Product Picture
Figure 5. Global Gaucher Disease Market Share by Application in 2020 & 2027
Figure 6. Non-neuronopathic Gaucher Disease
Figure 7. Neuronopathic Gaucher Disease
Figure 8. Global Gaucher Disease Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Gaucher Disease Market Size 2016-2027 (US$ Million)
Figure 10. Global Gaucher Disease Sales 2016-2027 (K Units)
Figure 11. Global Gaucher Disease Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Gaucher Disease Sales Share by Manufacturers in 2020
Figure 13. Global Gaucher Disease Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Gaucher Disease Players: Market Share by Revenue in 2020
Figure 15. Gaucher Disease Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Gaucher Disease Sales Market Share by Region (2016-2021)
Figure 17. Global Gaucher Disease Sales Market Share by Region in 2020
Figure 18. Global Gaucher Disease Revenue Market Share by Region (2016-2021)
Figure 19. Global Gaucher Disease Revenue Market Share by Region in 2020
Figure 20. U.S. Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Gaucher Disease Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Gaucher Disease by Type (2016-2021)
Figure 45. Sales Market Share of Gaucher Disease by Application (2016-2021)
Figure 46. Sales Market Share of Gaucher Disease by Application in 2020
Figure 47. Revenue Share of Gaucher Disease by Application (2016-2021)
Figure 48. Revenue Share of Gaucher Disease by Application in 2020
Figure 49. Manufacturing Cost Structure of Gaucher Disease
Figure 50. Manufacturing Process Analysis of Gaucher Disease
Figure 51. Gaucher Disease Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi Takeda Actelion Pharma Pfizer (Protalix) ISU ABXIS